DB19067InvestigationalProtein Based Therapies
VIS-410 is under investigation in clinical trial NCT03040141 (Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A).
- Also known as
- IMMUNOGLOBULIN G1, ANTI-(INFLUENZA HEMAGGLUTININ) (HUMAN MONOCLONAL VIS410 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIS410 .KAPPA.-CHAIN, DIMER
- Code names
- VIS-410
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of VIS-410, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account